Target intelligence / Profile preview

Organic solute transporter subunit beta (SLC51B)

Target
SLC51B
Molecular classification
Transporter, Solute carrier family protein (SLC family), Heterodimeric organic solute transporter (forms part of OSTα-OSTβ complex)
01

Overview

Organic solute transporter subunit beta (SLC51B) is a single-pass transmembrane protein that partners with SLC51A (OSTα) to form the OSTα-OSTβ heterodimer. This transporter is essential for the basolateral export of bile acids, conjugated steroids, and prostaglandin E2 from epithelial cells, especially in the small intestine, liver, kidney, and other tissues involved in steroid and bile acid circulation. The SLC51A/SLC51B complex is required for normal bile acid absorption and dietary lipid uptake, acts independently of sodium, and is subject to adaptive transcriptional regulation in response to changes in bile acid load, often mediated via the FXR nuclear receptor. Mutations or absence of transporter function lead to profound alterations in bile acid and lipid metabolism. OSTβ is necessary for glycosylation and membrane targeting of OSTα, and both subunits must heterodimerize for stability and trafficking. Several clinically used drugs are known to inhibit OSTα/OSTβ-mediated transport. Increased expression of this transporter is found in cholestatic liver disease, supporting its role in hepatic bile acid adaptation and protection against toxicity.

Other names
OST-betaOSTBOSTBETASolute carrier family 51 subunit betaSLC51A1 binding proteinSLC51A1BPPBAM2Organic solute transporter beta subunit
02

Mechanism of action

Inhibition of bile acid and steroid conjugate efflux or uptake (by competitive blockade of the transporter); Modulation of intestinal/liver/kidney bile acid homeostasis; FXR-dependent transcriptional regulation alters transporter expression and function

03

Biological functions

Bile acid and bile salt transmembrane transportConjugated steroid transportProstaglandin E2 transportPositive regulation of protein exit from endoplasmic reticulumPositive regulation of protein glycosylation and targeting to membraneRegulation of protein stabilityFacilitated diffusion across basolateral membranes (intestine, liver, kidney)
04

Disease associations

Cholestatic liver disease (protective and adaptive regulation)Disorders of bile acid transport and homeostasisLipid absorption disordersPrimary biliary cirrhosis, primary biliary cholangitis, nonalcoholic steatohepatitis, liver injury adaptationOther (potential roles in steroid-related conditions, renal bile acid salvage)
05

Safety considerations

No clinically significant polymorphisms reportedLoss of function leads to impaired bile acid absorption and reduced lipid uptakePotential compensatory changes in other bile acid transportersNo reported drug-drug or food-drug interactions requiring regulatory investigationGenetic deficiency may protect against liver injury from oral bile acid loading, but causes global bile acid depletion
06

Interacting drugs

Digoxin (substrate/inhibitor)

9 more in the full profile.

07

Biomarkers

Increased OSTα/OSTβ mRNA/protein in liver tissue (upregulated in cholestatic liver disease, primary biliary cirrhosis/cholangitis)Serum bile acid levels (reduced with transporter deficiency)Changes in bile acid and lipid profiles, compensatory upregulation of related transporters and enzymes (e.g. ASBT, Mrp3, Cyp7a1)

Beyond the preview

Go deeper on Organic solute transporter subunit beta (SLC51B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organic solute transporter subunit beta (SLC51B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call